Timothy Kieffer
Directeur Technique/Scientifique/R&D chez FRACTYL HEALTH, INC.
Fortune : - $ au 30/06/2024
Postes actifs de Timothy Kieffer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| FRACTYL HEALTH, INC. | Directeur Technique/Scientifique/R&D | 01/09/2023 | - |
Historique de carrière de Timothy Kieffer
Anciens postes connus de Timothy Kieffer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | 01/09/2021 | 01/10/2022 |
| University of British Columbia | Corporate Officer/Principal | 01/01/2007 | - |
Formation de Timothy Kieffer
| University of British Columbia | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Canada | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FRACTYL HEALTH, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Timothy Kieffer
- Expérience
